PETER J GRAHAM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER J GRAHAM.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER J GRAHAM. PETER J GRAHAM is a SVP - Chief Legal Officer in E-Z-EM, Inc. ($EZM) and a VP - General Counsel in E-Z-EM, Inc. ($EZM) and a EVP General Counsel, Secretary in ANTARES PHARMA, INC. ($ATRS) and a SVP General Counsel, Secretary in ANTARES PHARMA, INC. ($ATRS).
Address: 1111 MARCUS AVENUE SUITE LL-26 LAKE SUCCESS 110421034 NY
Companies in which PETER J GRAHAM is an Insider
ANTARES PHARMA, INC.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PETER J GRAHAM: EVP General Counsel, Secretary, SVP General Counsel, Secretary
Holdings: 582,490 shares
Current Value: $1,281,478
Latest Transaction: Feb 19 2021
$ATRS Market Capitalization: $356.70M
$ATRS Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
E-Z-EM, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of PETER J GRAHAM: SVP - Chief Legal Officer, VP - General Counsel
Holdings: 0 shares
Latest Transaction: Apr 02 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER J GRAHAM
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | M | 1.12 | 45,000 | 50,400 | 0 | |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Sell | S | 5.05 | 5,000 | 25,250 | 540,417 | 545.4 K to 540.4 K (-0.92 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Sell | S | 4.91 | 40,000 | 196,400 | 545,417 | 585.4 K to 545.4 K (-6.83 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Buy | M | 1.12 | 45,000 | 50,400 | 585,417 | 540.4 K to 585.4 K (+8.33 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Payment of Exercise | F | 4.73 | 42,073 | 199,005 | 540,417 | 582.5 K to 540.4 K (-7.22 %) |
| Feb 19 2021 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Grant | A | 0.00 | 80,365 | 0 | 582,490 | 502.1 K to 582.5 K (+16.00 %) |
| Jun 15 2020 | ATRS | ANTARES PHARMA, IN ... | GRAHAM PETER J | EVP General Counsel ... | Option Exercise | A | 2.73 | 254,165 | 693,870 | 254,165 |